Healthcare identity management solutions provider Verato has announced a partnership with Redox, a healthcare integration provider, to combine their expertise in creating a more accurate and trusted identity record for patients, members, providers and communities.

The partnership will leverage Verato’s referential matching technology and Redox’s composable technology ecosystem to improve data access, interoperability and quality across the healthcare digital ecosystem for hospitals and care centres, among others.

The solutions will help collect data from multiple sources, analyse and organise it, and ensure that records for a single patient, member or provider are matched accurately and automatically across systems.

According to the press release, around 30% of patient demographic data is inaccurate, incomplete or outdated, and nearly 35% of denied insurance claims are caused by incorrect patient matching, which can result in hospitals losing an average of $2.5m per year.

Redox CEO Luke Bonney said: “Unfortunately, we don’t live in an ideal world and many healthcare organisations are stymied by inaccurate or incorrect data but also struggle to quickly implement effective solutions to address this challenge.”  

The partnership plans to improve matching accuracy, and drive higher-quality decision-making, operational efficiency and an improved experience for hospitals and patients.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Verato CEO Clay said: “We are proud to offer Verato technology as a solution to Redox customers’ identification and data challenges, ultimately enabling these organisations to move into the future, drastically improving patient care and operations”.

The partnership has already launched a new solution called Redox Chroma EMPI powered by Verato, which integrates easily with organisations’ existing technology suites to create a full and accurate identity record for each person they serve.